USA-USFDACVM-2026-US-013917
Received 2026-03-25 · MSK · MSK
- Species
- Dog
- Size / weight
- 10-24 lb (4.536 Kilogram)
- Age
- 8+ years (12 Year)
- Sex
- Male Neutered
- Region
- USA
- Reactions
- Lateral recumbencyAgonal breathingDeath
- Body systems
- Other
- Outcomes
- Died
Roxee Medication Guide
Maropitant
Medication reference facts with explicit FDA-approval, off-label, source-limited, and safety context. Roxee does not sell, prescribe, or dispense medications.
Both
Reference complete
FDA data linked
Rx required
Tablet
Multiple FDA sponsors
Official label facts
Owner quick guide first
Veterinary professional?
Showing simplified owner view. Switch to Vet View for full technical detail.
Data freshness
Reference facts
Reference refreshed
Aug 6, 2026, 7:46 p.m.
These are the reference facts Roxee uses on browse cards and quick facts.
FDA applications
FDA application data refreshed
Aug 6, 2026, 7:46 p.m.
Sponsor, product, and application records imported from Animal Drugs @ FDA.
Safety reports
Safety data refreshed
Aug 6, 2026, 7:49 p.m.
openFDA reaction terms and case summaries are supporting evidence, not proof of causality.
Source timing details
Source timing details
-
Reference facts:
Source Roxee
| Refreshed Aug 6, 2026, 7:46 PM UTC
The reference fact projection used for browse cards and quick facts.
-
Animal Drugs @ FDA:
Source FDA
| Refreshed Aug 6, 2026, 7:46 PM UTC
Applications/products are imported from FDA export data.
-
Animal Drugs @ FDA previews:
Source FDA
| Refreshed Feb 9, 2026, 3:05 AM UTC
Label highlights/doc links are fetched from FDA preview endpoints.
- openFDA reaction terms: Source FDA openFDA | Refreshed Aug 6, 2026, 7:52 PM UTC
- openFDA case summaries: Source FDA openFDA | Refreshed Aug 6, 2026, 7:52 PM UTC
Illustration placeholder
Maropitant
Maropitant
Drug type: Generic ingredient • Generic profile • No FDA branded products linked
Both
Tablet
Rx required
100% reference complete
Species: Both
Manufacturer: Multiple FDA sponsors
Medication Snapshot
Merged from the current Roxee medication system with field-level provenance, freshness, and completeness tracking.
Maropitant
For the prevention of acute vomiting. For the prevention of vomiting due to motion sickness. For Prevention and Treatment of Acute Vomiting in Dogs: Dogs 2-4 Months of Age: Species commonly shown: Both, Dog, Cat.
Generic name
Maropitant
Brand names
Cerenia® Tablets, Cerenia® Injectable Solution, Maropitant Citrate, Maropitant Citrate Tablets
Manufacturer
Multiple FDA sponsors
Species
Both, Dog, Cat
Dosage forms
Tablet, Liquid (Solution), Injectable Solution, Chewable Tablets
Prescription
Prescription required
Completeness
100%
Validation
Needs review
Brand names
Cerenia® Tablets
Cerenia® Injectable Solution
Maropitant Citrate
Maropitant Citrate Tablets
Dosage forms
Tablet
Liquid (Solution)
Injectable Solution
Chewable Tablets
Indications / Uses
For the prevention of acute vomiting. For the prevention of vomiting due to motion sickness. For Prevention and Treatment of Acute Vomiting in Dogs: Dogs 2-4 Months of Age:
Warnings / Contraindications
For oral use in dogs only. Federal law restricts this drug to use by or on the order of a licensed veterinarian. For oral use in dogs only. Federal law restricts this drug to use by or on the order of a licensed veterinarian. CERENIA injectable solution should not be used interchangeably with CERENIA tablets for the prevention of vomiting due to motion sickness (8mg/kg). Federal law restricts this drug to use by or on the order of a licensed veterinarian. The safe use of CERENIA Injectable Solution has not been evaluated in dogs or cats with gastrointestinal obstruction or that have ingested toxins. The safe use of CERENIA Injectable Solution has not been evaluated in dogs or cats used for breeding, or in pregnant or lactating bitches or queens.
- For oral use in dogs only. Federal law restricts this drug to use by or on the order of a licensed veterinarian. For oral use in dogs only. Federal law restricts this drug to use by or on the order of a licensed veterinarian. CERENIA injectable solution should not be used interchangeably with CERENIA tablets for the prevention of vomiting due to motion sickness (8mg/kg). Federal law restricts this drug to use by or on the order of a licensed veterinarian. The safe use of CERENIA Injectable Solution has not been evaluated in dogs or cats with gastrointestinal obstruction or that have ingested toxins. The safe use of CERENIA Injectable Solution has not been evaluated in dogs or cats used for breeding, or in pregnant or lactating bitches or queens.
Side Effects
Top reported reactions (openFDA): Vomiting, Diarrhoea, Death by euthanasia, Lethargy (see also Central nervous system depression in 'Neurological'), Lethargy (see also Central nervous system depression in Neurological), Not eating.
FAQ
Both, Dog, Cat
Yes. Roxee shows this as prescription-only.
Tablet, Liquid (Solution), Injectable Solution, Chewable Tablets
Related Conditions
Source Transparency
- Verified source: https://www.roxee.ai/meds/
- Verified source: https://animaldrugsatfda.fda.gov
- Verified source: https://api.fda.gov/animalandveterinary/event.json
- Verified source: https://www.roxee.ai/conditions/
- Verified source: https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/820
- Verified source: https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/17776
- Last refreshed: Aug 6, 2026, 7:46 p.m.
- Last verified: Apr 15, 2026, 10:04 a.m.
- Validation status: Needs review
Add to My Pet's Medications
Choose a pet, confirm current or past, and optionally add reminder notes.
Sign in to save this medication to your pet profile.
Sign in to continuePet Owner Quick Guide
Start here first for the safest next-step summary before the deeper medication detail.
Used for:
For the prevention of acute vomiting and the prevention of vomiting due to motion sickness in dogs.
Dosing note:
Exact dosing depends on your pet's species, weight, and health status. Use your veterinarian's instructions for the exact dose and schedule.
What to watch for:
- For oral use in dogs only
- CERENIA injectable solution should not be used interchangeably with CERENIA tablets for the prevention of vomiting due to motion sickness (8mg/kg)
- The safe use of CERENIA Injectable Solution has not been evaluated in dogs or cats with gastrointestinal obstruction or that have ingested toxins
- The safe use of CERENIA Injectable Solution has not been evaluated in dogs or cats used for breeding, or in pregnant or lactating bitches or queens
- Hepatomegaly (4 reports)
- Hypokalaemia (3 reports)
- Anaphylaxis (3 reports)
When to call the vet:
- Repeated vomiting or diarrhea.
- Severe lethargy (hard to wake, very low energy).
- Collapse or fainting.
- Trouble breathing.
- Facial swelling or hives.
- Blood in vomit or stool.
Regulatory restrictions are shown in Vet View.
What to tell or ask your vet today:
- Is this medicine the right fit for my pet’s current symptoms?
- Which warning signs mean I should call back right away?
- How should I handle missed doses or refusal to take the medicine?
Research brief
Medication Research Insights
A source-aware map of what to know, what is uncertain, and what to verify with your veterinarian.
What to know
Evidence-backed context
Limited
Roxee has limited cited overview evidence for Maropitant; use the official documents and your veterinarian's instructions for product-specific decisions.
Source: openFDA reaction aggregate term
Safety signal coverage
Reported signals
32 tracked reaction signals; 62 reported cases; 3 serious reports; 2 species groups. These are reporting and label-derived signals for interpretation with a veterinarian.
Source: openFDA reaction aggregate term
Interpretation guardrail
Not causation
Adverse-event reports help form a watch list, but they do not prove the medication caused the reaction and they are not a risk ranking between medications.
Evidence tension
Stronger signal
Label / review
Official labels, package inserts, and reviewed summaries carry more weight than isolated reports.
Source: openFDA reaction aggregate term
Weaker signal
Reported data
Case reports and openFDA terms are useful for pattern awareness, but they are incomplete, can include multiple exposures, and do not estimate an individual pet's probability of harm.
Reaction signal map
Most reported reactions
Top terms
Hepatomegaly (4 reports), Hypokalaemia (3 reports), Anaphylaxis (3 reports), Wobbliness (2 reports), Vocalisation (2 reports)
Body systems represented
Signal grouping
Digestive (1), Skin & allergy (1), Effectiveness (1), Other (29)
Species and breed lens
Species represented in reports
Species lens
Dog (42 reports), Cat (20 reports)
Breed metadata in reports
Metadata only
Retriever - Labrador (2), Schnauzer - Miniature (1), Pug (1), ['Mastiff (unspecified)', 'Crossbred Canine/dog'] (1). These are report metadata, not proof that a breed is at higher risk.
What your vet may verify
Fit for this patient
Vet check
Verify whether Maropitant fits the pet's species, current diagnosis, age, weight, organ status, pregnancy/lactation status, and concurrent medications.
Evidence limitations
Evidence review
Separate label-backed warnings from adverse-event reports and owner observations before changing the plan.
What to watch next
Watch list
Owner-safe
For oral use in dogs only, CERENIA injectable solution should not be used interchangeably with CERENIA tablets for the preventi, The safe use of CERENIA Injectable Solution has not been evaluated in dogs or cats with gastrointest, The safe use of CERENIA Injectable Solution has not been evaluated in dogs or cats used for breeding, Hepatomegaly
Call sooner if
Escalation
Repeated vomiting or diarrhea. Severe lethargy (hard to wake, very low energy). Collapse or fainting.
Bottom line: Use this Maropitant brief as a structured watch list and source map, not as a reason to start, stop, or change treatment without your veterinarian.
Vet source depth
- openFDA reaction aggregate term · adverse_reaction · adverse reactions
- Contraindication source · fda_animal_drugs · warnings contraindications
- FDA application profile · official_label · quick facts
- FDA application profile · official_label · quick facts
- Medication usage source · fda_animal_drugs · quick facts
- FOI · document · documents
- SPL · document · documents
- FOI · document · documents
Evidence
Review status / Updated / Sources
Review status: Clinical reviewer not listed
Updated: April 15, 2026, 10:04 AM UTC
Sources:
- FDA application profile · official_label
- FDA application profile · official_label
- Medication usage source · fda_animal_drugs
- Maropitant Citrate Tablets · official_label
- openFDA reaction aggregate term · adverse_reaction
Safety & side effects
Side effects to monitor:
- For oral use in dogs only
- CERENIA injectable solution should not be used interchangeably with CERENIA tablets for the prevention of vomiting due to motion sickness (8mg/kg)
- The safe use of CERENIA Injectable Solution has not been evaluated in dogs or cats with gastrointestinal obstruction or that have ingested toxins
- The safe use of CERENIA Injectable Solution has not been evaluated in dogs or cats used for breeding, or in pregnant or lactating bitches or queens
- Hepatomegaly
Most reported reactions:
- Hepatomegaly (4 reports)
- Hypokalaemia (3 reports)
- Anaphylaxis (3 reports)
Emergency warning signs:
- Repeated vomiting or diarrhea.
- Severe lethargy (hard to wake, very low energy).
- Collapse or fainting.
- Trouble breathing.
Vet Fast Scan
Source-backed clinical checkpoints for quick review.
FDA-labeled species
Cat, Dog
Indication / use
For the prevention of acute vomiting and the prevention of vomiting due to motion sickness in dogs.
Form / route / dose
Form: Chewable Tablets, Injectable Solution, Liquid (Solution), Tablet
Route: Intravenous, Oral, Subcutaneous
Confirm product label and patient-specific plan.
Route: Intravenous, Oral, Subcutaneous
Confirm product label and patient-specific plan.
Warnings
- High: For oral use in dogs only. Federal law restricts this drug to use by or on the order of a licensed veterinarian. For or…
Adverse-event caveat
openFDA adverse-event cases are reported signals. They are not verified, do not prove causation, and do not estimate a pet's individual risk.
Source docs
Quick Facts
Official label facts first, then secondary summaries. Marketing content is separated below.
Species: Both
Manufacturer: Multiple FDA sponsors
Form: Chewable Tablets, Injectable Solution, Liquid (Solution), Tablet
Identifiers:
ANADA: 200710
ANADA: 200747
ANADA: 200785
ANADA: 200833
NADA: 141262
NADA: 141263
NDC Package: 11695-7029-1
NDC Package: 11695-7029-2
NDC Package: 11695-7030-1
NDC Package: 11695-7030-2
NDC Package: 11695-7031-1
NDC Package: 11695-7031-2
NDC Package: 11695-7032-1
NDC Package: 11695-7032-2
NDC Package: 11695-7054-1
NDC Package: 11695-7054-2
NDC Package: 11695-7055-1
NDC Package: 11695-7055-2
NDC Package: 11695-7056-1
NDC Package: 11695-7056-2
Source metadata:
- https://animaldrugsatfda.fda.gov/adafda/views/#/home/previewsearch/200833 · official_label · FDA application profile
- https://animaldrugsatfda.fda.gov/adafda/views/#/home/previewsearch/200710 · official_label · FDA application profile
- https://animaldrugsatfda.fda.gov · fda_animal_drugs · Medication usage source
Warnings / Contraindications
For oral use in dogs only. Federal law restricts this drug to use by or on the order of a licensed veterinarian. For oral use in dogs only. Federal law restricts this drug to use by or on the order of a licensed veterinarian. CERENIA injectable solution should not be used interchangeably with CERENIA tablets for the prevention of vomiting due to motion sickness (8mg/kg). Federal law restricts this drug to use by or on the order of a licensed veterinarian. The safe use of CERENIA Injectable Solution has not been evaluated in dogs or cats with gastrointestinal obstruction or that have ingested toxins. The safe use of CERENIA Injectable Solution has not been evaluated in dogs or cats used for breeding, or in pregnant or lactating bitches or queens.
- High: For oral use in dogs only. Federal law restricts this drug to use by or on the order of a licensed veterinarian. For oral use in dogs only. Federal law restricts this drug to use by or on the order of a licensed veterinarian. CERENIA injectable solution should not be used interchangeably with CERENIA tablets for the prevention of vomiting due to motion sickness (8mg/kg). Federal law restricts this drug to use by or on the order of a licensed veterinarian. The safe use of CERENIA Injectable Solution has not been evaluated in dogs or cats with gastrointestinal obstruction or that have ingested toxins. The safe use of CERENIA Injectable Solution has not been evaluated in dogs or cats used for breeding, or in pregnant or lactating bitches or queens.
Source metadata:
- https://animaldrugsatfda.fda.gov · fda_animal_drugs · Contraindication source
Adverse Reactions
Snapshot first, detailed rows second. This section summarizes signal data and is not a diagnosis.
Reported case explorer
Filter stored openFDA reports by pet and report attributes. Counts describe reports in this data set, not risk.
openFDA adverse-event cases are reported signals. They are not verified, do not prove causation, and do not estimate a pet's individual risk.
Stored reports
170
Matching reports
30
Active filters
1
Selected filters
Reaction: Death
Clear
Drill into common report signals
Showing up to 50 matching reports.
USA-USFDACVM-2026-US-012910
Received 2026-03-18 · MSK · MSK
- Species
- Dog
- Breed
- Deutsche Dogge, Great Dane
- Size / weight
- 100+ lb (47.174 Kilogram)
- Age
- 8+ years (1 Year)
- Sex
- Female Unknown
- Region
- USA
- Reactions
- VomitingAppetite lossLethargy (see also Central nervous system depression in Neurological)Heavy breathingDeath
- Body systems
- DigestiveNeurologicOther
- Outcomes
- Died
USA-USFDACVM-2026-US-014092
Received 2026-03-16 · MSK · MSK
- Species
- Cat
- Breed
- Domestic Shorthair
- Size / weight
- Under 10 lb (4.354 Kilogram)
- Age
- 4-7 years (7 Year)
- Sex
- Female Neutered
- Region
- USA
- Reactions
- DroolingReluctant to moveNot eatingDilated pupilsNot himself/herselfHypothermiaTachypnoeaIntentional misuseLeukopenia NOSHypoglycaemiaElevated symmetrical dimethylarginine (SDMA)AzotaemiaLow ionized calcium (Ca; Hypocalcaemia, ionized)ObtundedWeak pulseLateral recumbencyRegurgitationCardiac arrestDeath
- Body systems
- DigestiveOther
- Outcomes
- Died
USA-USFDACVM-2026-US-014083
Received 2026-03-13 · MSK · MSK
- Species
- Dog
- Breed
- American Pit Bull Terrier
- Size / weight
- 50-99 lb (26.4 Kilogram)
- Age
- 4-7 years (4 Year)
- Sex
- Male Neutered
- Region
- USA
- Reactions
- Cardiac arrestDeath
- Body systems
- Other
- Outcomes
- Died
USA-USFDACVM-2026-US-013398
Received 2026-03-11 · MSK · MSK
- Species
- Cat
- Breed
- Domestic Shorthair
- Size / weight
- 10-24 lb (6 Kilogram)
- Age
- 4-7 years (5 Year)
- Sex
- Male Neutered
- Region
- USA
- Reactions
- FallingSeizure NOSDeathRigidity
- Body systems
- OtherNeurologic
- Outcomes
- Died
USA-USFDACVM-2026-US-011296
Received 2026-03-11 · MSK · MSK
- Species
- Cat
- Breed
- Domestic Mediumhair
- Size / weight
- Under 10 lb (3.629 Kilogram)
- Age
- 8+ years (12 Year)
- Sex
- Female Unknown
- Region
- USA
- Reactions
- Tendon rupturePancreas disorderDeath
- Body systems
- Other
- Outcomes
- Died
USA-USFDACVM-2026-US-012018
Received 2026-03-10 · MSK · MSK
- Species
- Cat
- Breed
- Domestic Shorthair
- Size / weight
- Under 10 lb (2.95 Kilogram)
- Age
- 8+ years (13.8 Year)
- Sex
- Male Neutered
- Region
- USA
- Reactions
- Death
- Body systems
- Other
- Outcomes
- Died
USA-USFDACVM-2026-US-009874
Received 2026-03-05 · MSK · MSK
- Species
- Cat
- Breed
- Domestic Shorthair
- Size / weight
- Under 10 lb (2.522 Kilogram)
- Age
- 8+ years (13 Year)
- Sex
- Female Unknown
- Region
- USA
- Reactions
- DeathIntentional misuse
- Body systems
- Other
- Outcomes
- Died
USA-USFDACVM-2026-US-010347
Received 2026-03-03 · MSK · MSK
- Species
- Dog
- Breed
- ['Shepherd Dog - German', 'Retriever - Labrador']
- Size / weight
- 50-99 lb (29.166 Kilogram)
- Age
- 8+ years (1 Year)
- Sex
- Female Unknown
- Region
- USA
- Reactions
- LimpingMusculoskeletal disorder NOSLocal swelling (not application site)Hot spot (pyotraumatic dermatitis)LickingNot himself/herselfElevated serum alkaline phosphatase (ALP)Elevated blood urea nitrogen (BUN)Elevated creatinineNeutrophiliaDeathMedication error NOS
- Body systems
- OtherSkin & allergy
- Outcomes
- Died
USA-USFDACVM-2026-US-009973
Received 2026-02-27 · MSK · MSK
- Species
- Dog
- Breed
- Crossbred Canine/dog
- Size / weight
- 50-99 lb (34.019 Kilogram)
- Age
- 8+ years (10.5 Year)
- Sex
- Male Neutered
- Region
- USA
- Reactions
- Not eatingWalking difficultyPantingSeizure NOSDeathIntentional misuse
- Body systems
- OtherNeurologic
- Outcomes
- Died
USA-USFDACVM-2026-US-013389
Received 2026-02-23 · MSK · MSK
- Species
- Dog
- Breed
- Shih Tzu
- Size / weight
- 10-24 lb (5.4 Kilogram)
- Age
- 8+ years (14.91 Year)
- Sex
- Male Neutered
- Region
- USA
- Reactions
- CoughDeathPneumonia
- Body systems
- Other
- Outcomes
- Died
USA-USFDACVM-2026-US-007776
Received 2026-02-20 · MSK · MSK
- Species
- Cat
- Breed
- Maine Coon
- Size / weight
- Under 10 lb (4.4 Kilogram)
- Age
- 8+ years (19 Year)
- Sex
- Female Unknown
- Region
- USA
- Reactions
- Elevated globulinsHyperglycaemiaLeukocytosis NOSLethargy (see also Central nervous system depression in Neurological)SneezingNasal dischargePyrexiaNeuropathy NOSEpistaxisHypocalcaemiaUnable to walkMedication error NOSDeath
- Body systems
- OtherNeurologic
- Outcomes
- Died
USA-USFDACVM-2026-US-007171
Received 2026-02-18 · MSK · MSK
- Species
- Dog
- Breed
- Shih Tzu
- Size / weight
- 10-24 lb (5.4 Kilogram)
- Age
- 8+ years (14.91 Year)
- Sex
- Male Neutered
- Region
- USA
- Reactions
- CoughDeathPneumonia
- Body systems
- Other
- Outcomes
- Died
USA-USFDACVM-2026-US-011611
Received 2026-02-14 · MSK · MSK
- Species
- Cat
- Breed
- Domestic Shorthair
- Size / weight
- 10-24 lb (6.3 Kilogram)
- Age
- 4-7 years (6 Year)
- Sex
- Male Neutered
- Region
- USA
- Reactions
- DeathDullNot himself/herselfHead pressingHypotensionUnresponsive to stimuli
- Body systems
- Other
- Outcomes
- Died
USA-USFDACVM-2026-US-005003
Received 2026-02-04 · MSK · MSK
- Species
- Dog
- Breed
- Rottweiler
- Size / weight
- 50-99 lb (4 Kilogram)
- Age
- 8+ years (1 Year)
- Sex
- Female Unknown
- Region
- USA
- Reactions
- Addison's diseaseLethargy (see also Central nervous system depression in Neurological)FebrileDecreased pulse oxygenationAspiration pneumoniaHypotensionElevated lactateHind limb paresisReduced reflexesDeath
- Body systems
- OtherNeurologic
- Outcomes
- Died
USA-USFDACVM-2026-US-005800
Received 2026-02-02 · MSK · MSK
- Species
- Cat
- Breed
- Domestic Shorthair
- Size / weight
- 10-24 lb (6.3 Kilogram)
- Age
- 4-7 years (6 Year)
- Sex
- Male Neutered
- Region
- USA
- Reactions
- DeathDullNot himself/herselfHead pressingHypotensionUnresponsive to stimuli
- Body systems
- Other
- Outcomes
- Died
USA-USFDACVM-2025-US-074994
Received 2025-12-17 · MSK · MSK
- Species
- Cat
- Breed
- Maine Coon
- Size / weight
- 10-24 lb (6.58 Kilogram)
- Age
- 8+ years (13 Year)
- Sex
- Male Neutered
- Region
- USA
- Reactions
- TwitchingFocal seizureDeathLethargy (see also Central nervous system depression in Neurological)
- Body systems
- Skin & allergyNeurologicOther
- Outcomes
- Died
USA-USFDACVM-2025-US-075245
Received 2025-12-16 · MSK · MSK
- Species
- Dog
- Breed
- Retriever - Golden
- Size / weight
- 10-24 lb (6.622 Kilogram)
- Age
- Under 1 year (2 Month)
- Sex
- Male Intact
- Region
- USA
- Reactions
- WeaknessNot eatingLying downInappropriate urinationDifficulty standingWalking slowlyCollapse NOS (see also Cardio-vascular and Neurological disorders)Pain NOSSneezingCough, productiveInvoluntary urinationUnable to walkLeucocytosis NOSAnaemia NOSDecreased blood urea nitrogen (BUN) or creatinineAbdominal painGastric ulcerSeizure NOSDeathLack of efficacy - NOS
- Body systems
- OtherNeurologicEffectiveness
- Outcomes
- Died
USA-USFDACVM-2025-US-074459
Received 2025-12-16 · MSK · MSK
- Species
- Dog
- Breed
- Retriever - Labrador
- Size / weight
- 50-99 lb (33.339 Kilogram)
- Age
- 8+ years (8 Year)
- Sex
- Female Unknown
- Region
- USA
- Reactions
- Immune mediated haemolytic anaemiaDeathAnaemia NOSThrombocytopeniaNeutrophiliaHeart murmurVomitingIcterusPantingNot eatingOther abnormal test result NOSElevated alanine aminotransferase (ALT)Elevated total bilirubinElevated serum alkaline phosphatase (ALP)ThrombocytosisHaemolysis NOSMedication error NOSMonocytosisLarge plateletsSpherocytosisAgglutination test, positive
- Body systems
- OtherDigestive
- Outcomes
- Died
USA-USFDACVM-2025-US-074431
Received 2025-12-16 · MSK · MSK
- Species
- Dog
- Breed
- ['Retriever - Golden', 'Poodle - Standard']
- Size / weight
- 50-99 lb (43.273 Kilogram)
- Age
- 4-7 years (7 Year)
- Sex
- Male Neutered
- Region
- USA
- Reactions
- ThrombocytopeniaBlood loss NOSSkin petechiaeDeath
- Body systems
- Other
- Outcomes
- Died
USA-USFDACVM-2025-US-073827
Received 2025-12-15 · MSK · MSK
- Species
- Dog
- Breed
- Shepherd Dog - Australian
- Size / weight
- Under 10 lb (4.037 Kilogram)
- Age
- Under 1 year (7 Month)
- Sex
- Female Unknown
- Region
- USA
- Reactions
- DroolingAnorexiaDeathMuscle tremorTirednessIntestinal disorder NOS
- Body systems
- DigestiveOtherNeurologic
- Outcomes
- Died
USA-USFDACVM-2025-US-073005
Received 2025-12-08 · MSK · MSK
- Species
- Dog
- Breed
- ['Bichon Frise', 'Poodle - Miniature']
- Size / weight
- 10-24 lb (8.21 Kilogram)
- Age
- 8+ years (16 Year)
- Sex
- Female Unknown
- Region
- USA
- Reactions
- WeaknessLethargy (see also Central nervous system depression in Neurological)Unable to standUrine leakageAnaemia NOSElevated creatinineDistension of abdomenCoughPale mucous membraneTachypnoeaShiveringDeathElevated temperature
- Body systems
- OtherNeurologic
- Outcomes
- Died
USA-USFDACVM-2025-US-071565
Received 2025-12-03 · MSK · MSK
- Species
- Dog
- Breed
- Dog (unknown)
- Size / weight
- 25-49 lb (14.969 Kilogram)
- Age
- 8+ years (15 Year)
- Sex
- Male Neutered
- Region
- USA
- Reactions
- Head tilt - neurological disorder (see also Head tilt - ear disorder)Walking difficultyVomitingSkin and tissue infection NOSGeneral illnessDeath
- Body systems
- NeurologicOtherDigestive
- Outcomes
- Died
USA-USFDACVM-2025-US-071673
Received 2025-12-02 · MSK · MSK
- Species
- Dog
- Breed
- Retriever - Labrador
- Size / weight
- 50-99 lb (24.494 Kilogram)
- Age
- 8+ years (13 Year)
- Sex
- Male Intact
- Region
- USA
- Reactions
- BloatedStaggeringDeathDry heavingDistension of abdomen
- Body systems
- Other
- Outcomes
- Died
USA-USFDACVM-2025-US-072468
Received 2025-12-01 · MSK · MSK
- Species
- Dog
- Breed
- ['Shih Tzu', 'Spitz - German Pomeranian']
- Size / weight
- Under 10 lb (3.4 Kilogram)
- Age
- 8+ years (8 Year)
- Sex
- Female Neutered
- Region
- USA
- Reactions
- Seizure NOSDeath
- Body systems
- NeurologicOther
- Outcomes
- Died
USA-USFDACVM-2025-US-070810
Received 2025-12-01 · MSK · MSK
- Species
- Dog
- Breed
- ['Shih Tzu', 'Spitz - German Pomeranian']
- Size / weight
- Under 10 lb (3.402 Kilogram)
- Age
- 8+ years (8 Year)
- Sex
- Female Neutered
- Region
- USA
- Reactions
- Seizure NOSDeathMedication error NOSNot eatingLeucocytosis NOSPain NOSElevated lactateHyperglycaemiaAbdominal discomfortAbnormal radiograph findingNeutrophiliaMonocytosisElevated triglyceride
- Body systems
- NeurologicOther
- Outcomes
- Died
USA-USFDACVM-2025-US-071591
Received 2025-11-26 · MSK · MSK
- Species
- Dog
- Breed
- ['Poodle (unspecified)', 'Retriever - Golden']
- Size / weight
- 50-99 lb (34.473 Kilogram)
- Age
- 4-7 years (5 Year)
- Sex
- Female Neutered
- Region
- USA
- Reactions
- DeathBreathing difficulty
- Body systems
- Other
- Outcomes
- Died
USA-USFDACVM-2025-US-067364
Received 2025-11-14 · MSK · MSK
- Species
- Cat
- Breed
- Domestic Shorthair
- Size / weight
- 10-24 lb (6.804 Kilogram)
- Age
- 8+ years (14 Year)
- Sex
- Female Unknown
- Region
- USA
- Reactions
- DehydrationEmesis (multiple)Elevated cholesterol (total)Abnormal radiograph findingLack of efficacy - NOSWeaknessUrinary incontinenceAtaxiaDullRecumbencyIncreased coagulation timeElevated aspartate aminotransferase (AST)Elevated creatinineHypokalaemiaElevated gamma-glutamyl transferase (GGT)Elevated triglycerideBlood in urineHypothermiaDisseminated intravascular coagulationCardiorespiratory arrestDeathIntentional misuseShockDistension of abdomen
- Body systems
- OtherDigestiveEffectivenessNeurologic
- Outcomes
- Died
USA-USFDACVM-2025-US-068234
Received 2025-11-12 · MSK · MSK
- Species
- Cat
- Breed
- Cat (unknown)
- Sex
- Mixed Unknown
- Region
- USA
- Reactions
- DeathHaematocheziaDecreased appetiteRegurgitationLethargy (see also Central nervous system depression in Neurological)DiarrhoeaDeath by euthanasia
- Body systems
- OtherDigestiveNeurologic
- Outcomes
- DiedEuthanizedOutcome Unknown
USA-USFDACVM-2025-US-062675
Received 2025-10-21 · MSK · MSK
- Species
- Dog
- Breed
- Dachshund - Standard Long-haired
- Size / weight
- 10-24 lb (5.996 Kilogram)
- Age
- 8+ years (15 Year)
- Sex
- Female Unknown
- Region
- USA
- Reactions
- Lethargy (see also Central nervous system depression in Neurological)SedationLying downElevated temperatureTachycardiaDeathUnresponsive to stimuli
- Body systems
- NeurologicOther
- Outcomes
- Died
Tap or hover a reaction to see what it means in plain language.
Tracked signals
32
Reported cases
62
Serious reports
3
Species represented
2
Grouped by Body System
Digestive (1)
· Drooling
Skin & allergy (1)
· Hives
Effectiveness (1)
· Lack of efficacy (endoparasite) - tapeworm
Other (29)
· Hepatomegaly, Hypokalaemia, Anaphylaxis
Most Reported Reactions
| Reaction | Body system | Cases | Species | Serious cases |
|---|---|---|---|---|
| Other | 4 | Cat | 0 | |
| Other | 3 | Cat | 0 | |
| Other | 3 | Dog | 0 | |
| Other | 2 | Cat | 0 | |
| Other | 2 | Dog | 0 | |
| Other | 2 | Dog | 0 | |
| Other | 2 | Cat | 0 | |
| Other | 2 | Dog | 0 |
Species coverage: Dog (42) Cat (20)
View detailed reaction table
| Reaction | Body system | Species | Seriousness | Frequency | Reports |
|---|---|---|---|---|---|
| Other | Cat | Unknown | - | 4 | |
| Other | Cat | Unknown | - | 3 | |
| Other | Dog | Unknown | - | 3 | |
| Other | Cat | Unknown | - | 2 | |
| Other | Dog | Unknown | - | 2 | |
| Other | Dog | Unknown | - | 2 | |
| Other | Cat | Unknown | - | 2 | |
| Other | Dog | Unknown | - | 2 | |
| Other | Dog | Unknown | - | 2 | |
| Other | Dog | Unknown | - | 2 | |
| Other | Dog | Unknown | - | 2 | |
| Other | Dog | Unknown | - | 2 | |
| Other | Dog | Unknown | - | 2 | |
| Other | Dog | Unknown | - | 2 | |
| Effectiveness | Dog | Unknown | - | 2 | |
| Other | Dog | Unknown | - | 2 | |
| Other | Dog | Unknown | - | 2 | |
| Skin & allergy | Dog | Unknown | - | 2 | |
| Other | Dog | Unknown | - | 2 | |
| Other | Dog | Unknown | - | 2 | |
| Other | Cat | Unknown | - | 2 | |
| Digestive | Dog | Unknown | - | 2 | |
| Other | Dog | Unknown | - | 2 | |
| Other | Cat | Unknown | - | 2 | |
| Other | Cat | Unknown | - | 2 | |
| Other | Cat | Unknown | - | 2 | |
| Other | Dog | Serious | - | 1 | |
| Other | Dog | Unknown | - | 1 | |
| Other | Dog | Non-serious | - | 1 | |
| Other | Cat | Unknown | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 |
Source metadata:
- https://api.fda.gov/animalandveterinary/event.json · adverse_reaction · openFDA reaction aggregate term
Source Documents
The most useful source links appear first; full previews and metadata stay in the veterinary/professional layer.
Use original documents to confirm product-specific warnings, ingredients, and handling details with your veterinarian.
Maropitant Citrate Tablets
SPL · SPL
Maropitant Citrate
SPL · SPL
Maropitant Citrate Tablets
SPL · SPL
Full source previews and metadata remain in the veterinary/professional layer.
Owner handouts
0No owner handouts linked yet.
Official label / PI
0No official label or package insert links yet.
SPL
6FOI
10Maropitant Citrate Tablets
SPL · SPL
FDA Structured Product Label
Maropitant Citrate Tablets
Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.
- Sponsor
- Felix Pharmaceuticals Pvt. Ltd.
- ANADA
- 200-833
- Status
- RX
- Form
- Chewable Tablets
- Route
- Oral
Composition / specifications
16 mg, 24 mg, 60 mg, or 160 mg of maropitant as maropitant citrate per tablet
Dogs
Indication
For the prevention of acute vomiting and the prevention of vomiting due to motion sickness in dogs.
Dosage
For Prevention of Acute Vomiting in dogs 2 - 7 months of age: Administer Maropitant Citrate Tablets orally at a minimum dose of 2 mg/kg (0.9 mg/lb) body weight once daily for up to 5 consecutive days.
For Prevention of Acute Vomiting in dogs 7 months of age and older: Administer Maropitant Citrate Tablets orally at a minimum dose of 2 mg/kg (0.9 mg/lb) body weight once daily until resolution of acute vomiting.
For Prevention of Vomiting due to motion sickness in dogs 4 months of age and older: Administer Maropitant Citrate Tablets orally at a minimum dose of 8 mg/kg (3.6 mg/lb) body weight once daily for up to 2 consecutive days.
Maropitant Citrate
SPL · SPL
FDA Structured Product Label
Maropitant Citrate
Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.
- Sponsor
- Dechra Veterinary Products LLC
- ANADA
- 200-710
- Status
- RX
- Form
- Injectable Solution
- Route
- Intravenous, Subcutaneous
Composition / specifications
Each mL contains 10 mg of maropitant as maropitant citrate
Dogs
Indication
For the prevention and treatment of acute vomiting.
Dosage
Administer 1.0 mg per kilogram (mg/kg) of body weight by subcutaneous or intravenous injection once daily for up to 5 consecutive days.
Cats
Indication
For the treatment of vomiting.
Dosage
Administer 1.0 mg/kg of body weight by subcutaneous or intravenous injection once daily for up to 5 consecutive days.
Maropitant Citrate Tablets
SPL · SPL
FDA Structured Product Label
Maropitant Citrate Tablets
Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.
- Sponsor
- Felix Pharmaceuticals Pvt. Ltd.
- ANADA
- 200-785
- Status
- RX
- Form
- Tablet
- Route
- Oral
Composition / specifications
16 mg, 24 mg, 60 mg, or 160 mg of maropitant citrate per tablet
Dogs
Indication
For the prevention of acute vomiting and the prevention of vomiting due to motion sickness in dogs.
Dosage
For Prevention of Acute Vomiting in dogs 2 -7 months of age: Administer orally at a minimum dose of 2 mg/kg (0.9 mg/lb) body weight once daily for up to 5 consecutive days.
For Prevention of Acute Vomiting in dogs 7 months of age and older: Administer orally at a minimum dose of 2 mg/kg (0.9 mg/lb) body weight once daily until resolution of acute vomiting.
For Prevention of Vomiting due to motion sickness in dogs 4 months of age and older: Administer orally at a minimum dose of 8 mg/kg (3.6 mg/lb) body weight once daily for up to 2 consecutive days.
Maropitant Citrate
SPL · SPL
FDA Structured Product Label
Maropitant Citrate
Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.
- Sponsor
- ZyVet Animal Health, Inc.
- ANADA
- 200-747
- Status
- RX
- Form
- Tablet
- Route
- Oral
- Species
- Dog
Composition / specifications
16, 24, 60, or 160 mg of maropitant as maropitant citrate per tablet
Dogs (2-7 months of age)
Indication
For prevention of acute vomiting.
Dosage
Administer orally at a minimum dose of 2 mg/kg (0.9 mg/lb) body weight once daily for up to 5 consecutive days.
Dogs (7 months of age and older)
Indication
For prevention of acute vomiting.
Dosage
Administer orally at a minimum dose of 2 mg/kg (0.9 mg/lb) body weight once daily until resolution of acute vomiting.
Dogs (4 months of age and older)
Indication
For prevention of vomiting due to motion sickness.
Dosage
Administer orally at a minimum dose of 8 mg/kg (3.6 mg/lb) body weight once daily for up to 2 consecutive days.
Cerenia® Tablets
SPL · SPL
FDA Structured Product Label
Cerenia® Tablets
Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.
- Sponsor
- Zoetis Inc.
- NADA
- 141-262
- Status
- RX
- Form
- Tablet
- Route
- Oral
- Species
- Dog
Composition / specifications
Each tablet contains 16, 24, 60, or 160 milligrams (mg) maropitant as maropitant citrate.
Dogs (7 Months of Age and Older)
Indication
For the prevention of acute vomiting.
Dosage
Administer CERENIA Tablets orally at a minimum dose of 2 mg/kg (0.9 mg/lb) body weight once daily until resolution of acute vomiting.
Limitations
For oral use in dogs only.
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Dogs (4 Months of Age and Older)
Indication
For the prevention of vomiting due to motion sickness.
Dosage
Administer CERENIA Tablets orally at a minimum dose of 8 mg/kg (3.6 mg/lb) body weight
once daily for up to 2 consecutive days
Limitations
For oral use in dogs only.
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
CERENIA injectable solution should not be used interchangeably with CERENIA tablets for the prevention of vomiting due to motion sickness (8mg/kg).
Dogs (2-7 Months)
Indication
For the prevention of acute vomiting.
Dosage
Administer CERENIA Tablets orally at a minimum dose of 2 mg/kg (0.9 mg/lb) body weight once daily for up to 5 consecutive days
Limitations
For oral use in dogs only.
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Cerenia® Injectable Solution
SPL · SPL
FDA Structured Product Label
Cerenia® Injectable Solution
Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.
- Sponsor
- Zoetis Inc.
- NADA
- 141-263
- Status
- RX
- Form
- Liquid (Solution)
- Route
- Subcutaneous, Intravenous
- Species
- Dog • Cat
Composition / specifications
Each milliliter of solution contains 10 milligrams (mg) maropitant as maropitant citrate.
Dogs (2-4 Months of Age)
Indication
For Prevention and Treatment of Acute Vomiting in Dogs:
Dogs 2-4 Months of Age:
Dosage
Administer subcutaneously at 1 mg/kg (0.45 mg/lb) equal to 0.1 mL/kg (0.1 mL/2.2 lb) of body weight once daily for up to 5 consecutive days.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
The safe use of CERENIA Injectable Solution has not been evaluated in dogs or cats with gastrointestinal obstruction or that have ingested toxins.
The safe use of CERENIA Injectable Solution has not been evaluated in dogs or cats used for breeding, or in pregnant or lactating bitches or queens.
Dogs (4 Months of Age and Older)
Indication
For Prevention of Vomiting in Dogs 4 months of Age and Older Caused by Emetogenic Medications or Chemotherapeutic Agents.
Dosage
Administer intravenously over 1-2 minutes or subcutaneously at 1 mg/kg (0.45 mg/lb) of body weight one time, 45-60 minutes prior to use of emetogenic medications or chemotherapeutic agents.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
The safe use of CERENIA Injectable Solution has not been evaluated in dogs or cats with gastrointestinal obstruction or that have ingested toxins.
The safe use of CERENIA Injectable Solution has not been evaluated in dogs or cats used for breeding, or in pregnant or lactating bitches or queens.
Indication
For Prevention and Treatment of Acute Vomiting in Dogs:
Dogs 2-4 Months of Age:
Dosage
Administer intravenously over 1-2 minutes or subcutaneously at 1 mg/kg (0.45 mg/lb) equal to 0.1 mL/1 kg (1 mL/22 lb) of body weight once daily for up to 5 consecutive days.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
The safe use of CERENIA Injectable Solution has not been evaluated in dogs or cats with gastrointestinal obstruction or that have ingested toxins.
The safe use of CERENIA Injectable Solution has not been evaluated in dogs or cats used for breeding, or in pregnant or lactating bitches or queens.
Cats (4 Months of Age and Older)
Indication
For Treatment of Vomiting in Cats 4 Months of Age and Older
Dosage
Administer intravenously over 1-2 minutes or subcutaneously at 1 mg/kg (0.45 mg/lb) equal to 0.1 mL/kg (0.1 mL/2.2 lb) of body weight once daily for up to 5 consecutive days.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
The safe use of CERENIA Injectable Solution has not been evaluated in dogs or cats with gastrointestinal obstruction or that have ingested toxins.
The safe use of CERENIA Injectable Solution has not been evaluated in dogs or cats used for breeding, or in pregnant or lactating bitches or queens.
FOI Summary oA 200-833 Approved January 12, 2026.pdf
FOI · FOI
FOI Summary oA 200-710 Approved December 5, 2025.pdf
FOI · FOI
FOI Summary oA 200-785 Approved June 17, 2024.pdf
FOI · FOI
FOI Summary oA 200-747 Approved March 31, 2023.pdf
FOI · FOI
UCM453543.pdf
FOI · FOI
UCM050060.pdf
FOI · FOI
UCM484493.pdf
FOI · FOI
UCM314823.pdf
FOI · FOI
UCM314825.pdf
FOI · FOI
ucm062313.pdf
FOI · FOI
Source metadata:
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/17886 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/18228/Maropitant%20Citrate%20Tablets · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/17776 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/18133/Maropitant%20Citrate · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/15545 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/15805/Maropitant%20Citrate%20Tablets · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/13695 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/13897/Maropitant%20Citrate · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/817 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/816 · document · FOI
Veterinary reference (advanced)
Canonical medication sections are above. This legacy block remains available for deeper cross-reference without cluttering the primary workflow.
At a Glance
Quick facts and links to official labeling and safety signals.
Data freshness
-
Reference facts:
Source Roxee
| Refreshed Aug 6, 2026, 7:46 PM UTC
The reference fact projection used for browse cards and quick facts.
-
Animal Drugs @ FDA:
Source FDA
| Refreshed Aug 6, 2026, 7:46 PM UTC
Applications/products are imported from FDA export data.
-
Animal Drugs @ FDA previews:
Source FDA
| Refreshed Feb 9, 2026, 3:05 AM UTC
Label highlights/doc links are fetched from FDA preview endpoints.
- openFDA reaction terms: Source FDA openFDA | Refreshed Aug 6, 2026, 7:52 PM UTC
- openFDA case summaries: Source FDA openFDA | Refreshed Aug 6, 2026, 7:52 PM UTC
Official (FDA)
Identity: Generic ingredient
• No FDA branded products linked
No official FDA brand rows linked yet for this ingredient.
Case-reported brands (openFDA):
MSK
Catalog species: Both
•
FDA-labeled species: Cat, Dog
Rx/OTC: RX
Form/route:
Chewable Tablets, Injectable Solution, Liquid (Solution), Tablet
• Intravenous, Oral, Subcutaneous
Applications: ANADA 200-833 • ANADA 200-710 • ANADA 200-785 • ANADA 200-747 • NADA 141-262 • NADA 141-263
Explore
Related conditions:
Acute vomiting
Gastrointestinal (additional)
Linked using:
Fda_Label (0.95),
Fda_Label (0.95)
Diagnosis Codes
Diagnosis-code mappings are not available for this medication yet.
Counseling and Monitoring Highlights
Global Pet owner/Vet mode is controlled in the header. This section avoids duplicate in-page persona tabs.
Owner-facing counseling points
- For oral use in dogs only. Federal law restricts this drug to use by or on the order of a licensed veterinarian. For oral use in dogs only. Federal law restricts this drug to use by or on the order of a licensed veterinarian. CERENIA injectable solution should not be used interchangeably with CERENIA tablets for the prevention of vomiting due to motion sickness (8mg/kg). Federal law restricts this drug to use by or on the order of a licensed veterinarian. The safe use of CERENIA Injectable Solution has not been evaluated in dogs or cats with gastrointestinal obstruction or that have ingested toxins. The safe use of CERENIA Injectable Solution has not been evaluated in dogs or cats used for breeding, or in pregnant or lactating bitches or queens. (Contraindication, High)
Top reaction signals
Hepatomegaly (4)
Hypokalaemia (3)
Anaphylaxis (3)
Wobbliness (2)
Vocalisation (2)
Unclassifiable adverse event (2)
Syncope (2)
Respiratory tract infection NOS (2)
Identifiers & Packages
Normalized identifiers (NDC/NADA/ANADA) and package metadata from regulator listings.
Identifiers
ANADA: 200710
ANADA: 200747
ANADA: 200785
ANADA: 200833
NADA: 141262
NADA: 141263
NDC Package: 11695-7029-1
NDC Package: 11695-7029-2
NDC Package: 11695-7030-1
NDC Package: 11695-7030-2
NDC Package: 11695-7031-1
NDC Package: 11695-7031-2
NDC Package: 11695-7032-1
NDC Package: 11695-7032-2
NDC Package: 11695-7054-1
NDC Package: 11695-7054-2
NDC Package: 11695-7055-1
NDC Package: 11695-7055-2
NDC Package: 11695-7056-1
NDC Package: 11695-7056-2
NDC Package: 11695-7057-1
NDC Package: 11695-7057-2
NDC Package: 13612-0035-0
NDC Package: 13612-0035-1
| Package NDC | Product NDC | Form / Route | Status |
|---|---|---|---|
| 11695-7029-1 | 11695 | - | |
| 11695-7029-2 | 11695 | - | |
| 11695-7030-1 | 11695 | - | |
| 11695-7030-2 | 11695 | - | |
| 11695-7031-1 | 11695 | - | |
| 11695-7031-2 | 11695 | - | |
| 11695-7032-1 | 11695 | - | |
| 11695-7032-2 | 11695 | - | |
| 11695-7054-1 | 11695 | - | |
| 11695-7054-2 | 11695 | - | |
| 11695-7055-1 | 11695 | - | |
| 11695-7055-2 | 11695 | - | |
| 11695-7056-1 | 11695 | - | |
| 11695-7056-2 | 11695 | - | |
| 11695-7057-1 | 11695 | - | |
| 11695-7057-2 | 11695 | - | |
| 13612-0035-0 | 13612 | - | |
| 13612-0035-1 | 13612 | - | |
| 17033-004-01 | 17033 | - | |
| 17033-006-04 | 17033 | - |
Enriched Documents
Documents are tiered by source trust: Official, Clinical, Manufacturer, Marketing.
-
FOI Summary oA 200-833 Approved January 12, 2026.pdf
• FOI summary • Official
• Feb. 2, 2026
FDA FOI summary for application 200833
-
FOI Summary oA 200-710 Approved December 5, 2025.pdf
• FOI summary • Official
• Jan. 5, 2026
FDA FOI summary for application 200710
-
FOI Summary oA 200-785 Approved June 17, 2024.pdf
• FOI summary • Official
• July 1, 2024
FDA FOI summary for application 200785
-
FOI Summary oA 200-747 Approved March 31, 2023.pdf
• FOI summary • Official
• March 31, 2023
FDA FOI summary for application 200747
-
UCM050060.pdf
• FOI summary • Official
• Jan. 31, 2019
FDA FOI summary for application 141262
-
UCM453543.pdf
• FOI summary • Official
• Jan. 31, 2019
FDA FOI summary for application 141262
-
ucm062313.pdf
• FOI summary • Official
• June 1, 2016
FDA FOI summary for application 141263
-
UCM314825.pdf
• FOI summary • Official
• June 1, 2016
FDA FOI summary for application 141263
-
UCM314823.pdf
• FOI summary • Official
• June 1, 2016
FDA FOI summary for application 141263
-
UCM484493.pdf
• FOI summary • Official
• June 1, 2016
FDA FOI summary for application 141263
Data Sources & Change Log
Every non-trivial field is expected to include provenance and update timestamps.
Official 121
Clinical 9
Manufacturer 0
Marketing 0
Current Field Facts
- contraindications: For oral use in dogs only. Federal law restricts this drug to use by or on the order of a licensed veterinarian. For oral use in dogs only. Federal law restric… (Clinical, 2026-04-15)
- contraindications: For oral use in dogs only. Federal law restricts this drug to use by or on the order of a licensed veterinarian. For oral use in dogs only. Federal law restric… (Clinical, 2026-04-15)
- contraindications: For oral use in dogs only. Federal law restricts this drug to use by or on the order of a licensed veterinarian. For oral use in dogs only. Federal law restric… (Clinical, 2026-04-11)
- monitoring: Monitor blood glucose and ketones, hydration status, appetite, and clinical response at regular intervals. (Clinical, 2026-04-16)
- monitoring: Monitor blood glucose and ketones, hydration status, appetite, and clinical response at regular intervals. (Clinical, 2026-04-15)
- side_effects: Top reported reactions (openFDA): Vomiting, Diarrhoea, Death by euthanasia, Lethargy (see also Central nervous system depression in 'Neurological'), Lethargy (… (Clinical, 2026-04-11)
- usage: For the prevention of acute vomiting. For the prevention of vomiting due to motion sickness. For Prevention and Treatment of Acute Vomiting in Dogs: Dogs 2-4 M… (Clinical, 2026-04-15)
- usage: For the prevention of acute vomiting. For the prevention of vomiting due to motion sickness. For Prevention and Treatment of Acute Vomiting in Dogs: Dogs 2-4 M… (Clinical, 2026-04-15)
- usage: For the prevention of acute vomiting. For the prevention of vomiting due to motion sickness. For Prevention and Treatment of Acute Vomiting in Dogs: Dogs 2-4 M… (Clinical, 2026-04-11)
- contraindications: For oral use in dogs only. Federal law restricts this drug to use by or on the order of a licensed veterinarian. For oral use in dogs only. Federal law restric… (Official, 2026-04-22)
- contraindications: For oral use in dogs only. Federal law restricts this drug to use by or on the order of a licensed veterinarian. For oral use in dogs only. Federal law restric… (Official, 2026-02-12)
- indications: Dogs:Â For the prevention and treatment of acute vomiting.Cats:Â For the treatment of vomiting. For the prevention and treatment of acute vomiting in dogs. For… (Official, 2026-08-06)
- indications: Dogs:Â For the prevention and treatment of acute vomiting.Cats:Â For the treatment of vomiting. For the prevention and treatment of acute vomiting in dogs. For… (Official, 2026-08-05)
- indications: Dogs:Â For the prevention and treatment of acute vomiting.Cats:Â For the treatment of vomiting. For the prevention and treatment of acute vomiting in dogs. For… (Official, 2026-08-04)
- indications: Dogs:Â For the prevention and treatment of acute vomiting.Cats:Â For the treatment of vomiting. For the prevention and treatment of acute vomiting in dogs. For… (Official, 2026-08-03)
- indications: Dogs:Â For the prevention and treatment of acute vomiting.Cats:Â For the treatment of vomiting. For the prevention and treatment of acute vomiting in dogs. For… (Official, 2026-08-02)
- indications: Dogs:Â For the prevention and treatment of acute vomiting.Cats:Â For the treatment of vomiting. For the prevention and treatment of acute vomiting in dogs. For… (Official, 2026-08-01)
- indications: Dogs:Â For the prevention and treatment of acute vomiting.Cats:Â For the treatment of vomiting. For the prevention and treatment of acute vomiting in dogs. For… (Official, 2026-07-31)
- indications: Dogs:Â For the prevention and treatment of acute vomiting.Cats:Â For the treatment of vomiting. For the prevention and treatment of acute vomiting in dogs. For… (Official, 2026-07-30)
- indications: Dogs:Â For the prevention and treatment of acute vomiting.Cats:Â For the treatment of vomiting. For the prevention and treatment of acute vomiting in dogs. For… (Official, 2026-07-29)
Recent Revisions
- side_effects updated 2026-04-22 10:07 by etl_backfill • Backfilled from existing medication fields
- contraindications updated 2026-04-22 10:07 by etl_backfill • Backfilled from existing medication fields
- usage updated 2026-04-22 10:07 by etl_backfill • Backfilled from existing medication fields
- monitoring updated 2026-04-16 13:28 by curated_loader • Clinical monitoring context for feline diabetes management.
- usage updated 2026-04-16 13:28 by curated_loader • Usage statement from FDA warning letter and approved-product context.
- drug_profile_type updated 2026-04-16 13:28 by curated_loader • FDA source confirms Senvelgo as a branded approved product.
- manufacturer_name updated 2026-04-16 13:28 by curated_loader • FDA warning letter identifies the approved sponsor/manufacturer.
- brand_names updated 2026-04-16 13:28 by curated_loader • FDA warning letter references Senvelgo as the approved animal drug.
- approval_reference updated 2026-04-16 13:28 by curated_loader • Official FDA application reference for Senvelgo.
- side_effects updated 2026-04-15 10:07 by etl_backfill • Backfilled from existing medication fields
- contraindications updated 2026-04-15 10:07 by etl_backfill • Backfilled from existing medication fields
- usage updated 2026-04-15 10:07 by etl_backfill • Backfilled from existing medication fields
- monitoring updated 2026-04-15 10:07 by curated_loader • Clinical monitoring context for feline diabetes management.
- usage updated 2026-04-15 10:07 by curated_loader • Usage statement from FDA warning letter and approved-product context.
- drug_profile_type updated 2026-04-15 10:07 by curated_loader • FDA source confirms Senvelgo as a branded approved product.
- manufacturer_name updated 2026-04-15 10:07 by curated_loader • FDA warning letter identifies the approved sponsor/manufacturer.
- brand_names updated 2026-04-15 10:07 by curated_loader • FDA warning letter references Senvelgo as the approved animal drug.
- approval_reference updated 2026-04-15 10:07 by curated_loader • Official FDA application reference for Senvelgo.
- side_effects updated 2026-04-15 10:04 by etl_backfill • Backfilled from existing medication fields
- contraindications updated 2026-04-15 10:04 by etl_backfill • Backfilled from existing medication fields
FDA Products & Applications (Animal Drugs @ FDA)
Official sponsor/proprietary-name/application-status records linked by active ingredient.
| Product | Sponsor | Application | Status | Published |
|---|---|---|---|---|
|
Maropitant Citrate Tablets
RX
Maropitant
Chewable Tablets
• Oral
|
Felix Pharmaceuticals Pvt. Ltd. | ANADA 200-833 | Approved | Feb 2, 2026 |
|
Maropitant Citrate
RX
Maropitant
Injectable Solution
• Intravenous, Subcutaneous
|
Dechra Veterinary Products LLC | ANADA 200-710 | Approved | Jan 5, 2026 |
|
Maropitant Citrate Tablets
RX
Maropitant
Tablet
• Oral
|
Felix Pharmaceuticals Pvt. Ltd. | ANADA 200-785 | Approved | Jul 1, 2024 |
|
Maropitant Citrate
RX
Maropitant
Tablet
• Oral
|
ZyVet Animal Health, Inc. | ANADA 200-747 | Approved | Mar 31, 2023 |
|
Cerenia® Tablets
RX
Maropitant
Tablet
• Oral
|
Zoetis Inc. | NADA 141-262 | Approved | Jan 31, 2019 |
|
Cerenia® Injectable Solution
RX
Maropitant
Liquid (Solution)
• Subcutaneous, Intravenous
|
Zoetis Inc. | NADA 141-263 | Approved | Jun 1, 2016 |
Data source: FDA Animal Drugs @ FDA (public search export).
What It's For (FDA Label Highlights)
Extracted from FDA Animal Drugs @ FDA product labeling. Always confirm details with your veterinarian.
Composition / specifications
16 mg, 24 mg, 60 mg, or 160 mg of maropitant as maropitant citrate per tablet
Dogs
Indication
For the prevention of acute vomiting and the prevention of vomiting due to motion sickness in dogs.
Dosage
For Prevention of Acute Vomiting in dogs 2 - 7 months of age: Administer Maropitant Citrate Tablets orally at a minimum dose of 2 mg/kg (0.9 mg/lb) body weight once daily for up to 5 consecutive days.
For Prevention of Acute Vomiting in dogs 7 months of age and older: Administer Maropitant Citrate Tablets orally at a minimum dose of 2 mg/kg (0.9 mg/lb) body weight once daily until resolution of acute vomiting.
For Prevention of Vomiting due to motion sickness in dogs 4 months of age and older: Administer Maropitant Citrate Tablets orally at a minimum dose of 8 mg/kg (3.6 mg/lb) body weight once daily for up to 2 consecutive days.
Limitations
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
Each mL contains 10 mg of maropitant as maropitant citrate
Dogs
Indication
For the prevention and treatment of acute vomiting.
Dosage
Administer 1.0 mg per kilogram (mg/kg) of body weight by subcutaneous or intravenous injection once daily for up to 5 consecutive days.
Limitations
Cats
Indication
For the treatment of vomiting.
Dosage
Administer 1.0 mg/kg of body weight by subcutaneous or intravenous injection once daily for up to 5 consecutive days.
Limitations
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
16 mg, 24 mg, 60 mg, or 160 mg of maropitant citrate per tablet
Dogs
Indication
For the prevention of acute vomiting and the prevention of vomiting due to motion sickness in dogs.
Dosage
For Prevention of Acute Vomiting in dogs 2 -7 months of age: Administer orally at a minimum dose of 2 mg/kg (0.9 mg/lb) body weight once daily for up to 5 consecutive days.
For Prevention of Acute Vomiting in dogs 7 months of age and older: Administer orally at a minimum dose of 2 mg/kg (0.9 mg/lb) body weight once daily until resolution of acute vomiting.
For Prevention of Vomiting due to motion sickness in dogs 4 months of age and older: Administer orally at a minimum dose of 8 mg/kg (3.6 mg/lb) body weight once daily for up to 2 consecutive days.
Limitations
FDA page: Open in Animal Drugs @ FDA
Species: Dog
Composition / specifications
16, 24, 60, or 160 mg of maropitant as maropitant citrate per tablet
Dogs (2-7 months of age)
Indication
For prevention of acute vomiting.
Dosage
Administer orally at a minimum dose of 2 mg/kg (0.9 mg/lb) body weight once daily for up to 5 consecutive days.
Limitations
Dogs (7 months of age and older)
Indication
For prevention of acute vomiting.
Dosage
Administer orally at a minimum dose of 2 mg/kg (0.9 mg/lb) body weight once daily until resolution of acute vomiting.
Limitations
Dogs (4 months of age and older)
Indication
For prevention of vomiting due to motion sickness.
Dosage
Administer orally at a minimum dose of 8 mg/kg (3.6 mg/lb) body weight once daily for up to 2 consecutive days.
Limitations
FDA page: Open in Animal Drugs @ FDA
Species: Dog
Composition / specifications
Each tablet contains 16, 24, 60, or 160 milligrams (mg) maropitant as maropitant citrate.
Dogs (7 Months of Age and Older)
Indication
For the prevention of acute vomiting.
Dosage
Administer CERENIA Tablets orally at a minimum dose of 2 mg/kg (0.9 mg/lb) body weight once daily until resolution of acute vomiting.
Limitations
For oral use in dogs only.
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Dogs (4 Months of Age and Older)
Indication
For the prevention of vomiting due to motion sickness.
Dosage
Administer CERENIA Tablets orally at a minimum dose of 8 mg/kg (3.6 mg/lb) body weight
once daily for up to 2 consecutive days
Limitations
For oral use in dogs only.
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
CERENIA injectable solution should not be used interchangeably with CERENIA tablets for the prevention of vomiting due to motion sickness (8mg/kg).
Dogs (2-7 Months)
Indication
For the prevention of acute vomiting.
Dosage
Administer CERENIA Tablets orally at a minimum dose of 2 mg/kg (0.9 mg/lb) body weight once daily for up to 5 consecutive days
Limitations
For oral use in dogs only.
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
FDA page: Open in Animal Drugs @ FDA
Species: Dog • Cat
Composition / specifications
Each milliliter of solution contains 10 milligrams (mg) maropitant as maropitant citrate.
Dogs (2-4 Months of Age)
Indication
For Prevention and Treatment of Acute Vomiting in Dogs:
Dogs 2-4 Months of Age:
Dosage
Administer subcutaneously at 1 mg/kg (0.45 mg/lb) equal to 0.1 mL/kg (0.1 mL/2.2 lb) of body weight once daily for up to 5 consecutive days.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
The safe use of CERENIA Injectable Solution has not been evaluated in dogs or cats with gastrointestinal obstruction or that have ingested toxins.
The safe use of CERENIA Injectable Solution has not been evaluated in dogs or cats used for breeding, or in pregnant or lactating bitches or queens.
Dogs (4 Months of Age and Older)
Indication
For Prevention of Vomiting in Dogs 4 months of Age and Older Caused by Emetogenic Medications or Chemotherapeutic Agents.
Dosage
Administer intravenously over 1-2 minutes or subcutaneously at 1 mg/kg (0.45 mg/lb) of body weight one time, 45-60 minutes prior to use of emetogenic medications or chemotherapeutic agents.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
The safe use of CERENIA Injectable Solution has not been evaluated in dogs or cats with gastrointestinal obstruction or that have ingested toxins.
The safe use of CERENIA Injectable Solution has not been evaluated in dogs or cats used for breeding, or in pregnant or lactating bitches or queens.
Indication
For Prevention and Treatment of Acute Vomiting in Dogs:
Dogs 2-4 Months of Age:
Dosage
Administer intravenously over 1-2 minutes or subcutaneously at 1 mg/kg (0.45 mg/lb) equal to 0.1 mL/1 kg (1 mL/22 lb) of body weight once daily for up to 5 consecutive days.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
The safe use of CERENIA Injectable Solution has not been evaluated in dogs or cats with gastrointestinal obstruction or that have ingested toxins.
The safe use of CERENIA Injectable Solution has not been evaluated in dogs or cats used for breeding, or in pregnant or lactating bitches or queens.
Cats (4 Months of Age and Older)
Indication
For Treatment of Vomiting in Cats 4 Months of Age and Older
Dosage
Administer intravenously over 1-2 minutes or subcutaneously at 1 mg/kg (0.45 mg/lb) equal to 0.1 mL/kg (0.1 mL/2.2 lb) of body weight once daily for up to 5 consecutive days.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
The safe use of CERENIA Injectable Solution has not been evaluated in dogs or cats with gastrointestinal obstruction or that have ingested toxins.
The safe use of CERENIA Injectable Solution has not been evaluated in dogs or cats used for breeding, or in pregnant or lactating bitches or queens.
FDA page: Open in Animal Drugs @ FDA
Usage
For the prevention of acute vomiting. For the prevention of vomiting due to motion sickness. For Prevention and Treatment of Acute Vomiting in Dogs: Dogs 2-4 Months of Age:
Source: FDA Animal Drugs @ FDA • Reference
Contraindications
For oral use in dogs only. Federal law restricts this drug to use by or on the order of a licensed veterinarian. For oral use in dogs only. Federal law restricts this drug to use by or on the order of a licensed veterinarian. CERENIA injectable solution should not be used interchangeably with CERENIA tablets for the prevention of vomiting due to motion sickness (8mg/kg). Federal law restricts this drug to use by or on the order of a licensed veterinarian. The safe use of CERENIA Injectable Solution has not been evaluated in dogs or cats with gastrointestinal obstruction or that have ingested toxins. The safe use of CERENIA Injectable Solution has not been evaluated in dogs or cats used for breeding, or in pregnant or lactating bitches or queens.
Top Reported Reactions (openFDA)
De-duplicated reaction terms grouped by body system from FDA openFDA reports (not verified; does not prove causation).
Digestive
Drooling (2)
• Dog
Showing top 5 for Digestive.
Skin & allergy
Hives (2)
• Dog
Showing top 5 for Skin & allergy.
Effectiveness
Lack of efficacy (endoparasite) - tapeworm (2)
• Dog
Showing top 5 for Effectiveness.
Other
Hepatomegaly (4)
• Cat
Hypokalaemia (3)
• Cat
Anaphylaxis (3)
• Dog
Wobbliness (2)
• Cat
Vocalisation (2)
• Dog
Show more (24)
Unclassifiable adverse event (2)
• Dog
Syncope (2)
• Cat
Respiratory tract infection NOS (2)
• Dog
Reduced globulins (2)
• Dog
Not drinking (2)
• Dog
Muscle atrophy (2)
• Dog
Loose stool (2)
• Dog
Local erythema (2)
• Dog
Limb non-weight bearing (2)
• Dog
Injection site skin discolouration (2)
• Dog
Hypoproteinaemia (2)
• Dog
Fracture (2)
• Dog
Elevated temperature (2)
• Dog
Elevated gamma-glutamyl transferase (2)
• Cat
Conjunctivitis (2)
• Dog
Collapse NOS (2)
• Cat
Cardiac enlargement (2)
• Cat
Abdominal pain (2)
• Cat
Abnormal radiograph finding (1)
• Dog
Abnormal posture NOS (1)
• Dog
Abnormal histology NOS (1)
• Dog
Abnormal cytology (1)
• Cat
Abdominal discomfort (1)
• Dog
Abdominal cavity disorder NOS (1)
• Dog
Showing top 5 for Other.
Data source: FDA openFDA Animal & Veterinary adverse event reports.
Adverse Event Case Summaries (openFDA)
These are individual FDA adverse event reports. They are unverified and do not prove the medication caused the reaction.
Dog, Schnauzer - Miniature, Male, 5 year, 10.16 kilogram • Drug: MSK, Injection, Subcutaneous • Reactions: Lameness, Wobbliness, Tiredness (lethargy), Unable to walk, Weakness… • Outcome: Ongoing
- Report ID: USA-USFDACVM-2026-US-014449
- Serious AE: Yes
- Treated For AE: Yes
- Sex: Male
- Age: 5.00 Year
- Weight: 10.160 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Subcutaneous
- Form: Injection
Reactions Reported:
Lameness
Wobbliness
Tiredness (lethargy)
Unable to walk
Weakness
Fever
Immune-mediated polyarthritis
Gastritis
Abdominal cavity disorder NOS
Abnormal ultrasound finding
Hyperproteinaemia
Lymphopenia
Eosinopenia
Medication error NOS
Outcomes: Ongoing
Dog, Pug, Male, 3.75 year, 12.7 kilogram • Drug: MSK, Unknown • Reactions: Neurogenic keratoconjunctivitis sicca, Corneal ulcer, Nasal cavity disorder NOS, Abnormal Schirmer tear test • Outcome: Ongoing
- Report ID: USA-USFDACVM-2026-US-014105
- Serious AE: No
- Treated For AE: Yes
- Sex: Male
- Age: 3.75 Year
- Weight: 12.700 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Unknown
Reactions Reported:
Neurogenic keratoconjunctivitis sicca
Corneal ulcer
Nasal cavity disorder NOS
Abnormal Schirmer tear test
Outcomes: Ongoing
Dog, ['Mastiff (unspecified)', 'Crossbred Canine/dog'], Male, 1 year, 29.574 kilogram • Drug: MSK, Tablet, Oral, Dose: 60 Milligram per animal, Frequency: 1 per day • Reactions: Hypotension, Not eating, Nausea, Drowsiness - systemic disorder, Pain NOS… • Outcome: Euthanized
- Report ID: USA-USFDACVM-2026-US-014066
- Serious AE: Yes
- Treated For AE: Yes
- Sex: Male
- Age: 1.00 Year
- Weight: 29.574 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Oral
- Form: Tablet
- Dose: 60 Milligram per animal
- Frequency: 1 per day
Reactions Reported:
Hypotension
Not eating
Nausea
Drowsiness - systemic disorder
Pain NOS
Vomiting
Regurgitation
Discoloured urine
Cough
Crust
Hyperproteinaemia
Hypoalbuminaemia
Leukocytosis NOS
Neutrophilia
Fluid in abdomen NOS
Septicaemia
Intestinal disorder NOS
Abdominal cavity disorder NOS
Elevated lactate
Abnormal cytology
Duodenal ulcer
Intestinal perforation
Death by euthanasia
Lack of efficacy - NOS
Intentional misuse
Outcomes: Euthanized
Dog, Male, 12 year, 4.536 kilogram • Drug: MSK, Injection, Subcutaneous, Dose: 4.50 mL per dose, Frequency: 1 per day • Reactions: Lateral recumbency, Agonal breathing, Death • Outcome: Died
- Report ID: USA-USFDACVM-2026-US-013917
- Serious AE: Yes
- Treated For AE: No
- Sex: Male
- Age: 12.00 Year
- Weight: 4.536 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Subcutaneous
- Form: Injection
- Dose: 4.50 mL per dose
- Frequency: 1 per day
Reactions Reported:
Lateral recumbency
Agonal breathing
Death
Outcomes: Died
Cat, Domestic Longhair, Male, 5 month, 2.781 kilogram • Drug: MSK, Tablet, Oral, Dose: 8 Milligram per animal • Reactions: Increased respiratory rate, Breathing difficulty, Crackles on auscultation, Abnormal ultrasound finding, Pulmonary disorder NOS… • Outcome: Ongoing
- Report ID: USA-USFDACVM-2026-US-013761
- Serious AE: Yes
- Treated For AE: Yes
- Sex: Male
- Age: 5.00 Month
- Weight: 2.781 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Oral
- Form: Tablet
- Dose: 8 Milligram per animal
Reactions Reported:
Increased respiratory rate
Breathing difficulty
Crackles on auscultation
Abnormal ultrasound finding
Pulmonary disorder NOS
Intentional misuse
Decreased pulse oxygenation
Pale mucous membrane
Outcomes: Ongoing
Cat, Domestic Shorthair, Female, 19.7 week, 2.22 kilogram • Drug: MSK, Unknown • Reactions: Not himself/herself, Behavioral disorder (unspecified), Disorientation, Dilated pupils, Tiredness (lethargy)… • Outcome: Outcome Unknown
- Report ID: USA-USFDACVM-2026-US-014093
- Serious AE: Yes
- Treated For AE: Yes
- Sex: Female
- Age: 19.70 Week
- Weight: 2.220 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Unknown
Reactions Reported:
Not himself/herself
Behavioral disorder (unspecified)
Disorientation
Dilated pupils
Tiredness (lethargy)
Unsteady walking (ataxia)
Not eating
Outcomes: Outcome Unknown
Dog, Retriever - Labrador, Male, 10 year, 28.576 kilogram • Drug: MSK, Injection, Subcutaneous, Dose: 2.90 mL per animal • Reactions: Limping, Limb weakness, Cough, Neurological signs NOS, Wobbliness… • Outcome: Ongoing
- Report ID: USA-USFDACVM-2026-US-013484
- Serious AE: Yes
- Treated For AE: Yes
- Sex: Male
- Age: 10.00 Year
- Weight: 28.576 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Subcutaneous
- Form: Injection
- Dose: 2.90 mL per animal
Reactions Reported:
Limping
Limb weakness
Cough
Neurological signs NOS
Wobbliness
Collapse NOS
Fever
Joint pain
Joint swelling
Gait abnormality
Tense muscles
Elevated alanine aminotransferase
Elevated serum alkaline phosphatase
Hyperglycaemia
Neutrophilia
Abnormal radiograph finding
Immune-mediated polyarthritis
Blood in faeces
Medication error NOS
Outcomes: Ongoing
Dog, Retriever - Labrador, Male, 3 year, 28.576 kilogram • Drug: MSK, Tablet, Unknown • Reactions: Increased salivation, Drowsiness - systemic disorder • Outcome: Outcome Unknown
- Report ID: USA-USFDACVM-2026-US-013156
- Serious AE: No
- Treated For AE: No
- Sex: Male
- Age: 3.00 Year
- Weight: 28.576 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Unknown
- Form: Tablet
Reactions Reported:
Increased salivation
Drowsiness - systemic disorder
Outcomes: Outcome Unknown
Data source: FDA openFDA Animal & Veterinary adverse event reports.
Overdose Information
No approved overdose-management text is linked yet. If overdose is suspected, contact a veterinarian or emergency clinic immediately.
Storage & Handling
No approved storage guidance is linked yet for this ingredient. Use manufacturer packaging and veterinary guidance for handling/storage.
Share Your Thoughts
Let others know your experience or advice regarding this medication.
No community reviews yet. Be the first to share your experience.
This medication has not been reviewed by a veterinarian yet.
Medical Disclaimer: The medication details provided on Roxee are for informational purposes only and are not a substitute for professional veterinary advice. Always consult your veterinarian about your pet's specific needs.